Funds holding “TEVA PHARMACEUTICALS NE”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
18 positions across 15 funds, 7 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| MMT Aberdeen Multi-Market Income Fund Taxable Bonds | TEVA PHARMACEUTICALS NE | 88167AAS0 | DBT | 0.34% | $2.6M | Jul 31, 2026 | full (875 positions) |
| ERC Allspring Multi-Sector Income Fund Multi-Asset | TEVA PHARMACEUTICALS NE | 88167AAR2 | DBT | 0.25% | $997K | Jul 31, 2026 | full (464 positions) |
| ERH Allspring Utilities & High Income Fund High Yield | TEVA PHARMACEUTICALS NE | 88167AAR2 | DBT | 0.18% | $259K | May 31, 2026 | full (309 positions) |
| EVV Eaton Vance Ltd Duration Income Fund Taxable Bonds | TEVA PHARMACEUTICALS NE | 88167AAF8 | DBT | 0.12% | $2.1M | Jun 30, 2026 | full (1,518 positions) |
| BIT BlackRock Multi-Sector Income Trust Multi-Asset | TEVA PHARMACEUTICALS NE | 88167AAE1 | DBT | 0.11% | $820K | Jun 30, 2026 | full (1,493 positions) |
| BHK BlackRock Core Bond Trust Investment Grade | TEVA PHARMACEUTICALS NE | 88167AAE1 | DBT | 0.11% | $744K | Jun 30, 2026 | full (1,422 positions) |
| TSI TCW Strategic Income Fund Multi-Asset | TEVA PHARMACEUTICALS NE | 88167AAT8 | DBT | 0.09% | $321K | Jun 30, 2026 | full (729 positions) |
| EVG Eaton Vance Short Duration Diversified Income Fund Multi-Asset | TEVA PHARMACEUTICALS NE | 88167AAF8 | DBT | 0.08% | $150K | Jul 31, 2026 | full (897 positions) |
| EOD Allspring Global Dividend Opportunity Fund Global Equity | TEVA PHARMACEUTICALS NE | 88167AAR2 | DBT | 0.08% | $277K | Jul 31, 2026 | full (368 positions) |
| EVV Eaton Vance Ltd Duration Income Fund Taxable Bonds | TEVA PHARMACEUTICALS NE | 88167AAT8 | DBT | 0.07% | $1.2M | Jun 30, 2026 | full (1,518 positions) |
| AWF AllianceBernstein Global High Income Fund High Yield | TEVA PHARMACEUTICALS NE | 88167AAR2 | DBT | 0.06% | $571K | Jun 30, 2026 | full (1,236 positions) |
| BTZ BlackRock Credit Allocation Income Trust Taxable Bonds | TEVA PHARMACEUTICALS NE | 88167AAE1 | DBT | 0.06% | $676K | Jun 30, 2026 | full (1,766 positions) |
| BIT BlackRock Multi-Sector Income Trust Multi-Asset | TEVA PHARMACEUTICALS NE | 88167AAK7 | DBT | 0.05% | $409K | Jun 30, 2026 | full (1,493 positions) |
| AWF AllianceBernstein Global High Income Fund High Yield | TEVA PHARMACEUTICALS NE | 88167AAQ4 | DBT | 0.05% | $517K | Jun 30, 2026 | full (1,236 positions) |
| HYT BlackRock Corporate High Yield Fund High Yield | TEVA PHARMACEUTICALS NE | 88167AAE1 | DBT | 0.03% | $671K | Jun 30, 2026 | full (1,291 positions) |
| BLW BlackRock Ltd Duration Income Trust Taxable Bonds | TEVA PHARMACEUTICALS NE | 88167AAE1 | DBT | 0.02% | $95.6K | Jun 30, 2026 | full (1,781 positions) |
| DSU BlackRock Debt Strategies Fund Taxable Bonds | TEVA PHARMACEUTICALS NE | 88167AAE1 | DBT | 0.02% | $129K | Jun 30, 2026 | full (1,305 positions) |
| ECAT BlackRock ESG Capital Allocation Term Trust U.S. Equity | TEVA PHARMACEUTICALS NE | 88167AAE1 | DBT | 0.01% | $118K | Jun 30, 2026 | full (1,193 positions) |
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.